AT
Company Profile
Altamira Therapeutics
Basel, Switzerland
Leadership Team
Board of Directors
Nucleic Acid Programs
Other Programs
Bentrio Nasal Spray
Inner Ear Therapeutics
Investors & Media
Overview
0Products
0People
0Events
0Locations
Overview
Company details and contact information.
About
About Altamira Therapeutics Altamira Therapeutics is developing and supplying peptide-based nanoparticle technologies for efficient RNA delivery to extrahepatic tissues (xPhore™ platform). The Company currently has two flagship siRNA programs in preclinical development beyond in vivo proof of concept: AM-401 for KRAS driven cancer and AM-411 for rheumatoid arthritis.
- Address
- Peter Merian Strasse 90, Basel Basel-Stadt 4052, Switzerland